OKECHUKWU ANIAGOH-ALAKWE: Open Payments
NPI 1881231637 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,169 in 98 payments from 28 companies in 2025. Trend: 2023 $552 · 2024 $2,440 · 2025 $2,169
Food & beverage: $2,072Education: $97
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $606 |
| Abbott Laboratories | 9 | $200 |
| Amgen Inc. | 10 | $170 |
| Neurocrine BioSciences, Inc. | 5 | $133 |
| SANOFI-AVENTIS U.S. LLC | 5 | $122 |
| Sequel Med Tech, LLC | 5 | $102 |
| Amneal Pharmaceuticals LLC | 3 | $80 |
| Mannkind Corporation | 4 | $76 |
| Corcept Therapeutics | 3 | $75 |
| Ascendis Pharma Endocrinology Inc | 3 | $73 |
Products named: Ozempic, FREESTYLE LIBRE 3, CRENESSITY, TZIELD, EVENITY, TWIIST, Wegovy, Sogroya.
Industry payments across TX — which companies pay providers there.
